HOME / Notice / News / EN
https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=001&oid=016&aid=0001824826 NKCL launches ‘NK Immune Biome Core 1,2,3’, the human microbiome restoration program. NKCL had launched the product, ‘NK Immune Biome Core 1,2,3’ which recovers the balance of gut bacteria in ord...
https://news.mt.co.kr/mtview.php?no=2021033114321879523 According to the research, ‘Global Biologics Contract Development and Manufacturing Organization (CDMO) Market, Forecast to 2022’, conducted by global market research firm, Frost & Sullivan, the market size will grow by 13.7% annually for ...
https://n.news.naver.com/article/215/0000940774 NKCL Bio Group has opened 15-weeks course on nutritional health and functional medicine in Yonsei University, for upcoming semester on this March. Previously, last October, NKCL opened a university course on immunity at Songwon University. This is the s...
https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=101&oid=014&aid=0004570475 [The Establishment Ceremony] On January 22nd, NKCL Bio Group Inc. has commenced Microbiome R&D Center, which will mark a new chapter of immunity and functional medicine. Due to COVID-19, the esta...
NKCL Bio Group establishes an incorporate laboratory, ‘NKCL Microbiome Research Institute.’ The institute will be managed and lead by Professor Yoon-Bokgeun, the best authority on Microbiome in Korea, and it is planned to not only finding new strains, researching metabolic products, and developing ...